Health Care & Life Sciences » Pharmaceuticals | Faron Pharmaceuticals Oyj

Faron Pharmaceuticals Oyj | Balance Sheet

Fiscal year is January-December. All values GBP Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
-
187.80
8,157.40
9,797.60
8,264.20
3,650.40
Total Accounts Receivable
37.40
31.00
609.50
1,083.20
2,064.70
847.30
Inventories
914.30
542.50
478.30
-
-
-
Other Current Assets
-
0.00
919.80
1,024.30
1,415.00
1,628.20
Total Current Assets
951.80
761.30
10,165.00
11,905.20
11,743.90
6,125.90
Net Property, Plant & Equipment
-
-
20.60
17.90
19.50
15.30
Total Investments and Advances
-
-
-
20.50
28.40
-
Intangible Assets
909.30
918.80
737.80
259.50
288.50
471.20
Other Assets
-
-
-
1,238.60
1,134.50
537.70
Total Assets
1,861.10
1,680.10
10,923.40
13,441.60
13,214.80
7,182.40
ST Debt & Current Portion LT Debt
489.20
-
180.60
79.40
300.00
Accounts Payable
37.40
7.80
321.30
1,725.10
-
Other Current Liabilities
921.80
1,282.00
1,117.30
2,163.90
6,851.10
Total Current Liabilities
1,448.50
1,289.80
1,619.20
3,968.40
7,151.10
Long-Term Debt
1,202.20
1,312.30
1,065.70
1,778.00
1,853.50
Other Liabilities
-
-
-
524.10
-
Total Liabilities
2,650.70
2,602.10
2,685.00
6,270.50
9,004.60
Common Equity (Total)
789.50
921.90
8,238.50
7,171.10
4,210.20
Total Shareholders' Equity
789.50
921.90
8,238.50
7,171.10
4,210.20
Total Equity
789.50
921.90
8,238.50
7,171.10
4,210.20
Liabilities & Shareholders' Equity
1,861.10
1,680.10
10,923.40
13,441.60
13,214.80

About Faron Pharmaceuticals Oyj

View Profile
Address
Joukahaisenkatu 6
Turku FP 20520
Finland
Employees -
Website http://www.faron.com
Updated 07/08/2019
Faron Pharmaceuticals Oy engages in the provision of biopharmaceutical development. The company focuses on novel treatments for medical conditions such as acute organ traumas, cancer immunotherapy and vascular damage. It operates through the Traumakine and Clevegen brands for acute respiratory distress syndrome, and for pre-clinical anti-Clever-1 antibody respectively.